Cabot Corporation $CBT Shares Purchased by Fuller & Thaler Asset Management Inc.

Key Points

• Fuller & Thaler Asset Management Inc. increased its stake in Cabot Corporation to $99.01 million, representing a 1.7% rise, and now owns 2.20% of the company.
• Cabot recently reported earnings of $1.90 per share, exceeding analysts' expectations, although revenues of $923 million fell short of the forecast of $957 million.
• The company declared a quarterly dividend of $0.45 per share, resulting in an annualized yield of 2.3% with a payout ratio of 23.53%.

Fuller & Thaler Asset Management Inc. increased its position in shares of Cabot Corporation (NYSE:CBT - Free Report) by 1.7% in the 1st quarter, according to the company in its most recent disclosure with the SEC. The fund owned 1,190,886 shares of the specialty chemicals company's stock after purchasing an additional 19,333 shares during the quarter. Fuller & Thaler Asset Management Inc. owned 2.20% of Cabot worth $99,010,000 as of its most recent filing with the SEC.

A number of other institutional investors also recently made changes to their positions in the stock. Beverly Hills Private Wealth LLC grew its position in shares of Cabot by 3.6% in the first quarter. Beverly Hills Private Wealth LLC now owns 3,918 shares of the specialty chemicals company's stock valued at $326,000 after purchasing an additional 135 shares during the period. Isthmus Partners LLC grew its position in shares of Cabot by 4.6% in the first quarter. Isthmus Partners LLC now owns 4,258 shares of the specialty chemicals company's stock valued at $354,000 after purchasing an additional 186 shares during the period. CWM LLC grew its position in shares of Cabot by 55.0% in the first quarter. CWM LLC now owns 600 shares of the specialty chemicals company's stock valued at $50,000 after purchasing an additional 213 shares during the period. GAMMA Investing LLC grew its position in shares of Cabot by 26.1% in the first quarter. GAMMA Investing LLC now owns 1,700 shares of the specialty chemicals company's stock valued at $141,000 after purchasing an additional 352 shares during the period. Finally, Captrust Financial Advisors grew its position in Cabot by 4.4% during the fourth quarter. Captrust Financial Advisors now owns 9,489 shares of the specialty chemicals company's stock valued at $866,000 after acquiring an additional 399 shares during the period. 93.18% of the stock is owned by institutional investors and hedge funds.

Cabot Stock Up 4.9%

Shares of CBT traded up $3.9020 during midday trading on Friday, reaching $83.0020. 366,335 shares of the company were exchanged, compared to its average volume of 427,283. The stock has a 50-day moving average price of $76.52 and a 200-day moving average price of $78.96. The company has a market cap of $4.42 billion, a price-to-earnings ratio of 10.85 and a beta of 0.87. Cabot Corporation has a 1-year low of $70.40 and a 1-year high of $117.46. The company has a current ratio of 2.13, a quick ratio of 1.41 and a debt-to-equity ratio of 0.66.

Cabot (NYSE:CBT - Get Free Report) last released its quarterly earnings results on Monday, August 4th. The specialty chemicals company reported $1.90 EPS for the quarter, topping the consensus estimate of $1.80 by $0.10. Cabot had a return on equity of 25.68% and a net margin of 11.14%.The business had revenue of $923.00 million for the quarter, compared to analysts' expectations of $957.29 million. Cabot has set its FY 2025 guidance at 7.150-7.500 EPS. Research analysts expect that Cabot Corporation will post 7.57 earnings per share for the current year.

Cabot Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Thursday, September 11th. Investors of record on Friday, August 29th will be paid a $0.45 dividend. This represents a $1.80 annualized dividend and a dividend yield of 2.2%. Cabot's dividend payout ratio (DPR) is 23.53%.

Insider Activity at Cabot

In related news, CEO Sean D. Keohane sold 114,436 shares of the business's stock in a transaction dated Thursday, August 14th. The stock was sold at an average price of $79.28, for a total value of $9,072,486.08. Following the transaction, the chief executive officer owned 361,518 shares in the company, valued at approximately $28,661,147.04. The trade was a 24.04% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Company insiders own 3.03% of the company's stock.

Wall Street Analyst Weigh In

A number of equities research analysts have issued reports on the company. UBS Group set a $82.00 price target on Cabot and gave the company a "neutral" rating in a research report on Tuesday, August 5th. Wall Street Zen downgraded Cabot from a "buy" rating to a "hold" rating in a research report on Wednesday, May 7th. One equities research analyst has rated the stock with a Buy rating, one has given a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat, Cabot currently has a consensus rating of "Hold" and a consensus price target of $92.33.

About Cabot

Cabot Corporation operates as a specialty chemicals and performance materials company. The company operates through two segments, Reinforcement Materials and Performance Chemicals. It offers reinforcing carbons that are used in tires as a rubber reinforcing agent and performance additive, as well as in industrial products, such as hoses, belts, extruded profiles, and molded goods; and engineered elastomer composites solutions.